| http://www.w3.org/ns/prov#value | - One potential source of value that Life Sciences has and other sectors do not is the presence of a number of large, well-capitalized businesses facing revenue cliffs who have consistently overpaid for assets (and therefore enabled valuable pre-IPO realization).
|
